Results 51 to 60 of about 333 (103)

Exposure the Hazardous Potential of Quinalphos: An In‐Depth Analysis for Environmental and Biological Effects on Human Health

IET Systems Biology, Volume 20, Issue 1, January/December 2026.
This study elucidates pesticide docking onto proteins encoded by differentially expressed genes, revealing interaction networks involving chemicals, genes, proteins, drugs and diseases. It highlights structural insights, regulatory pathways and potential therapeutic or environmental implications, providing a comprehensive understanding of the ...
Jyoti Kant Choudhari, Biju Prava Sahariah, Anand Kumar Jayapal, Jyotsna Choubey, Abhishek Tripathi   +4 more
wiley   +1 more source

Figure S2 - Supplemental material for Management of Acne Vulgaris With Trifarotene

, 2023
Supplemental material, Figure S2, for Management of Acne Vulgaris With Trifarotene by Jerry Tan, Rajeev Chavda, Hilary Baldwin and Brigitte Dreno in Journal of Cutaneous Medicine and ...
Brigitte Dreno (292705), Rajeev Chavda (9008731), Hilary Baldwin (14805081), Jerry Tan (5154317)   +3 more
core   +1 more source

Spotlight July–September 2026: What's New in JEADV—Editor‐in‐Chief's Selection

JEADV Clinical Practice, Volume 5, Issue 3, Page 763-768, September 2026.
Carle Paul
wiley   +1 more source

Acne tarda: Empfehlungen zu Einordnung, Therapie und Pflege als Ergebnis einer Expertendiskussion

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 1, Page 11-23, January 2026.
Zusammenfassung Acne tarda wird in der Literatur als Erwachsenenakne definiert, die laut den meisten Autoren bei Frauen ab 25 Jahren auftritt. Die Definitionen und Altersgrenzen variieren jedoch zwischen den Studien. Gängige Leitlinien berücksichtigen Erwachsenenakne bislang nur selten.
Matthias Augustin, Thomas Dirschka, Peter Arne Gerber, Martina Kerscher, Natalia Kirsten, Falk Ochsendorf   +5 more
wiley   +1 more source

Use of Dermocosmetics in Acne Management: A Middle East‐North Africa Consensus

International Journal of Dermatology, Volume 65, Issue 1, Page 93-100, January 2026.
ABSTRACT Background Acne in the Middle East and Northern Africa (MENA) is associated with high rates of post‐inflammatory hyperpigmentation and scarring, resulting from relatively high frequencies of darker or oily skin types, environmental factors, perceptions, and knowledge of acne and its treatment.
Sameer Zimmo, Hesham Zaher, Amal Said, Eman El Morsy, Noureddine Litaiem, Anwar Al Hammadi, Amal El Sayed, Martin Steinhoff   +7 more
wiley   +1 more source

Figure S1 - Supplemental material for Management of Acne Vulgaris With Trifarotene

, 2023
Supplemental material, Figure S1, for Management of Acne Vulgaris With Trifarotene by Jerry Tan, Rajeev Chavda, Hilary Baldwin and Brigitte Dreno in Journal of Cutaneous Medicine and ...
Brigitte Dreno (292705), Rajeev Chavda (9008731), Hilary Baldwin (14805081), Jerry Tan (5154317)   +3 more
core   +1 more source

Long-term safety and efficacy of trifarotene 50μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne [PDF]

, 2020
Treatment for both facial and truncal acne has not sufficiently been studied.To evaluate the long-term safety and efficacy of trifarotene in both facial and truncal acne.In a multicentre, open-label, 52-week study, patients with moderate facial and ...
Tanghetti Emil, Kemény Lajos, Draelos Zoe, Dirschka Thomas, Blume-Peytavi Ulrike, Graeber Michael, Eichenfield Lawrence, Alió Saenz Alessandra, Ahmad Faiz, Fowler Joseph, Cook-Bolden Fran, Rich Phoebe   +11 more
core   +1 more source

Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 667-676, October 2025.
ABSTRACT Background Drug safety has historically been understudied in pediatric populations, rendering them “therapeutic orphans.” Pediatric drug indications and dosages are often inferred by extrapolating safety, efficacy, and dosing data from adult studies, leading to widespread off‐label use.
Saurabh Rahurkar, Jiayi Ouyang, Pallavi Jonnalagadda, Xiaofu Liu, Shijun Zhang, Chien‐Wei Chiang, Lei Wang, Aditi Shendre, Lang Li   +8 more
wiley   +1 more source

Berberine is a Novel Mitochondrial Calcium Uniporter Inhibitor that Disrupts MCU‐EMRE Assembly

Advanced Science, Volume 12, Issue 17, May 8, 2025.
Berberine, a safe and FDA‐approved drug, is identified as a novel mitochondrial calcium uniporter (MCU) inhibitor. By disrupting MCU‐EMRE interaction, Berberine prevents mitochondrial calcium overload and protects against ischemia/reperfusion injury, offering a promising therapeutic strategy for diseases linked to mitochondrial calcium dysregulation ...
Haixin Zhao, Siqi Chen, Nian Cao, Wenjun Wu, Guangqin Liu, Jun Gao, Jiayi Chen, Ting Li, Dingyi Lu, Lingmin Zeng, Haizhen Zhu, Weina Zhang, Qing Xia, Teng Li, Tao Zhou, Xue‐Min Zhang, Ai‐Ling Li, Xin Pan   +17 more
wiley   +1 more source

Trifarotene (Aklief) for the Treatment of Acne

, 2020
Trifarotene (Aklief) is a topical retinoid labeled for the treatment of facial and truncal acne vulgaris in patients nine years and older.1 Similar to other retinoids, its exact mechanism of action is not known, but it may work by normalizing ...
McGraw, Candis, Osayande, Amimi
core   +1 more source